Methotrexate gel and betamethasone lotion in the treatment of Nail psoriasis

The comparative study of iontophoresis with methotrexate gel and betamethasone lotion in the treatment of nail psoriasis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/11/037985

Enrollment

Registered

2021-11-12

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris

Interventions

Intervention1: Methotrexate gel with iontophoresis: apply methotreaxte gel over nails and cover with aluminium foil and then patient hand is placed in a tub having water and iontophoresis plates. rout

Eligibility

Inclusion criteria

Inclusion criteria: patients above 18years of age and patients who are willing to undergo the procedure

Exclusion criteria

Exclusion criteria: -patients having pacemaker, metal orthopedic implant, intrauterine device, cardiac arrhythmias, hypersentivity to methotrexate gel and betamethasone - pregnancy and lactation -age less than 18 years - patients with hematological or hepatic disorders

Design outcomes

Primary

Measure	Time frame
decrease in the pits or any other changes in the nails. Iontophoresis is performed once a week in the first 4 weeks and subsequently every 2 weeks, completing a total of 6 sittingsTimepoint: decrease in the pits or any other changes in the nails at the end of 8 weeks and completed 6 sittings	—

Secondary

Measure	Time frame
NONETimepoint: NONE	—

Countries

India

Contacts

Public ContactDr Anirudha Gulanikar

Mahatma Gandhi Mission

agulanikar@hotmail.com9822377963

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026